Caveolin-1 regulates genomic action of the glucocorticoid receptor in neural stem cells

Molecular and Cellular Biology

Volumn 34, Issue 14, 2014, Pages 2611-2623

  Peffer, Melanie E ^a   Chandran, Uma R ^a   Luthra, Soumya ^a   Volonte, Daniela ^a   Galbiati, Ferruccio ^a   Garabedian, Michael J ^b   Paula Monaghan, A ^a   DeFranco, Donald B ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CAVEOLIN 1; GLUCOCORTICOID RECEPTOR; CHROMATIN; DEXAMETHASONE; GLUCOCORTICOID; SERINE;

ANIMAL CELL; ANIMAL CELL CULTURE; ANTIPROLIFERATIVE ACTIVITY; ARTICLE; CELL COMMUNICATION; CELL PROLIFERATION; CHROMATIN; GENE DELETION; GENOMICS; HORMONE RESPONSE; LIPID RAFT; MICROARRAY ANALYSIS; MOUSE; NEURAL STEM CELL; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; REGULATORY MECHANISM; ANIMAL; ANIMAL EMBRYO; C57BL MOUSE; DNA MICROARRAY; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENE INACTIVATION; GENETICS; METABOLISM; MOLECULAR GENETICS; PHOSPHORYLATION; REGULATORY SEQUENCE;

ANIMALS; BASE SEQUENCE; CAVEOLIN 1; CELL PROLIFERATION; CHROMATIN; DEXAMETHASONE; EMBRYO, MAMMALIAN; GENE EXPRESSION REGULATION; GENE KNOCKOUT TECHNIQUES; GLUCOCORTICOIDS; MICE; MICE, INBRED C57BL; MOLECULAR SEQUENCE DATA; NEURAL STEM CELLS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PHOSPHORYLATION; RECEPTORS, GLUCOCORTICOID; REGULATORY ELEMENTS, TRANSCRIPTIONAL; SERINE;

EID: 84902687970     PISSN: 02707306     EISSN: 10985549     Source Type: Journal    
DOI: 10.1128/MCB.01121-13     Document Type: Article

References (52)

1. George AA, Schiltz RL, Hager GL. 2009. Dynamic access of the glucocorticoid receptor to response elements in chromatin. Int. J. Biochem. Cell Biol. 41:214-224. http://dx.doi.org/10.1016/j.biocel.2008.09.019.
2. Rhen T, Cidlowski JA. 2005. Anti-inflammatory action of glucocorticoids: new mechanisms for old drugs. N. Engl. J. Med. 353:1711-1723. http://dx.doi.org/10.1056/NEJMra050541.
3. ACOG. 2011. ACOG Committee opinion no. 475: antenatal corticosteroid therapy for fetal maturation. Obstet. Gynecol. 117:422-424. http://dx.doi.org/10.1097/AOG.0b013e31820eee00.
4. Miller WL, Witchel SF. 2013. Prenatal treatment of congenital adrenal hyperplasia: risks outweigh benefits. Am. J. Obstet. Gynecol. 208:354-359. http://dx.doi.org/10.1016/j.ajog.2012.10.885.
5. Crowther CA, Doyle LW, Haslam RR, Hiller JE, Harding JE, Robinson JS. 2007. Outcomes at 2 years of age after repeat doses of antenatal corticosteroids. N. Engl. J. Med. 357:1179-1189. http://dx.doi.org/10.1056/NEJMoa071152.
6. Wapner RJ, Sorokin Y, Mele L, Johnson F, Dudley DJ, Spong CY, Peaceman AM, Leveno KJ, Malone F, Caritis SN, Mercer B, Harper M, Rouse DJ, Thorp JM, Ramin S, Carpenter MW, Gabbe SG. 2007. Long-term outcomes after repeat doses of antenatal corticosteroids. N. Engl. J. Med. 357:1190-1198. http://dx.doi.org/10.1056/NEJMoa071453.
7. Damsted SK, Born AP, Paulson OB, Uldall P. 2011. Exogenous glucocorticoids and adverse cerebral effects in children. Eur. J. Paediatr. Neurol. 15:465-477. http://dx.doi.org/10.1016/j.ejpn.2011.05.002.
8. Davis EP, Sandman CA, Buss C, Wing DA, Head K. 2013. Fetal glucocorticoid exposure is associated with preadolescent brain development. Biol. Psychiatr. 74:647-655. http://dx.doi.org/10.1016/j.biopsych.2013.03.009.
9. Sundberg M, Savola S, Hienola A, Korhonen L, Lindholm D. 2006. Glucocorticoid hormones decrease proliferation of embryonic neural stem cells through ubiquitin-mediated degradation of cyclin D1. J. Neurosci. 26:5402-5410. http://dx.doi.org/10.1523/JNEUROSCI.4906-05.2006.
10. Noguchi KK, Walls KC, Wozniak DF, Olney JW, Roth KA, Farber NB. 2008. Acute neonatal glucocorticoid exposure produces selective and rapid cerebellar neural progenitor cell apoptotic death. Cell Death Differ. 15:1582-1592. http://dx.doi.org/10.1038/cdd.2008.97.
11. Moors M, Bose R, Johansson-Haque K, EdoffK, Okret S, Ceccatelli S. 2012. Dickkopf 1 mediates glucocorticoid-induced changes in human neural progenitor cell proliferation and differentiation. Toxicol. Sci. 125:488-495. http://dx.doi.org/10.1093/toxsci/kfr304.
12. Sabolek M, Herborg A, Schwarz J, Storch A. 2006. Dexamethasone blocks astroglial differentiation from neural precursor cells. Neuroreport 17:1719-1723. http://dx.doi.org/10.1097/01.wnr.0000236862.08834.50.
13. Wagner K, Couillard-Despres S, Lehner B, BrockhoffG, Rivera FJ, Blume A, Neumann I, Aigner L. 2009. Prolactin induces MAPK signaling in neural progenitors without alleviating glucocorticoid-induced inhibition of in vitro neurogenesis. Cell Physiol. Biochem. 24:397-406. http://dx.doi.org/10.1159/000257432.
14. Oitzl MS, Champagne DL, van der Veen R, de Kloet ER. 2010. Brain development under stress: hypotheses of glucocorticoid actions revisited. Neurosci. Biobehav. Rev. 34:853-866. http://dx.doi.org/10.1016/j.neubiorev.2009.07.006.
15. Heitzer MD, Wolf IM, Sanchez ER, Witchel SF, DeFranco DB. 2007. Glucocorticoid receptor physiology. Rev. Endocrinol. Metab. Disord. 8:321-330. http://dx.doi.org/10.1007/s11154-007-9059-8.
16. Matthews L, Berry A, Ohanian V, Ohanian J, Garside H, Ray D. 2008. Caveolin mediates rapid glucocorticoid effects and couples glucocorticoid action to the antiproliferative program. Mol. Endocrinol. 22:1320-1330. http://dx.doi.org/10.1210/me.2007-0154.
17. Samarasinghe RA, Di Maio R, Volonte D, Galbiati F, Lewis M, Romero G, DeFranco DB. 2011. Nongenomic glucocorticoid receptor action regulates gap junction intercellular communication and neural progenitor cell proliferation. Proc. Natl. Acad. Sci. U. S. A. 108:16657-16662. http://dx.doi.org/10.1073/pnas.1102821108.
18. Hammes SR, Levin ER. 2011. Minireview: recent advances in extranuclear steroid receptor actions. Endocrinology 152:4489-4495. http://dx.doi.org/10.1210/en.2011-1470.
19. Anacker C, Cattaneo A, Musaelyan K, Zunszain PA, Horowitz M, Molteni R, Luoni A, Calabrese F, Tansey K, Gennarelli M, Thuret S, Price J, Uher R, Riva MA, Pariante CM. 2013. Role for the kinase SGK1 in stress, depression, and glucocorticoid effects on hippocampal neurogenesis. Proc. Natl. Acad. Sci. U. S. A. 110:8708-8713. http://dx.doi.org/10.1073/pnas.1300886110.
20. Bolstad BM, Irizarry RA, Astrand M, Speed TP. 2003. A comparison of normalization methods for high density oligonucleotide array databased on variance and bias. Bioinformatics 19:185-193. http://dx.doi.org/10.1093/bioinformatics/19.2.185.
21. Simon R, Lam A, Li MC, Ngan M, Menenzes S, Zhao Y. 2007. Analysis of gene expression data using BRB-ArrayTools. Cancer Inform. 3:11-17.
22. John S, Johnson TA, Sung MH, Biddie SC, Trump S, Koch-Paiz CA, Davis SR, Walker R, Meltzer PS, Hager GL. 2009. Kinetic complexity of the global response to glucocorticoid receptor action. Endocrinology 150:1766-1774. http://dx.doi.org/10.1210/en.2008-0863.
23. Anacker C, Cattaneo A, Luoni A, Musaelyan K, Zunszain PA, Milanesi E, Rybka J, Berry A, Cirulli F, Thuret S, Price J, Riva MA, Gennarelli M, Pariante CM. 2013. Glucocorticoid-related molecular signaling pathways regulating hippocampal neurogenesis. Neuropsychopharmacology 38:872-883. http://dx.doi.org/10.1038/npp.2012.253.
24. Kuo T, Lew MJ, Mayba O, Harris CA, Speed TP, Wang JC. 2012. Genome-wide analysis of glucocorticoid receptor-binding sites in myotubes identifies gene networks modulating insulin signaling. Proc. Natl. Acad. Sci. U. S. A. 109:11160-11165. http://dx.doi.org/10.1073/pnas.1111334109.
25. Fukumoto K, Morita T, Mayanagi T, Tanokashira D, Yoshida T, Sakai A, Sobue K. 2009. Detrimental effects of glucocorticoids on neuronal migration during brain development. Mol. Psychiatr. 14:1119-1131. http://dx.doi.org/10.1038/mp.2009.60.
26. Gobert RP, Joubert L, Curchod ML, Salvat C, Foucault I, Jorand-Lebrun C, Lamarine M, Peixoto H, Vignaud C, Fremaux C, Jomotte T, Francon B, Alliod C, Bernasconi L, Abderrahim H, Perrin D, Bombrun A, Zanoguera F, Rommel C, Hooft van Huijsduijnen R. 2009. Convergent functional genomics of oligodendrocyte differentiation identifies multiple autoinhibitory signaling circuits. Mol. Cell. Biol. 29:1538-1553. http://dx.doi.org/10.1128/MCB.01375-08.
27. Pantoja C, HuffJT, Yamamoto KR. 2008. Glucocorticoid signaling defines a novel commitment state during adipogenesis in vitro. Mol. Biol. Cell 19:4032-4041. http://dx.doi.org/10.1091/mbc. E08-04-0420.
28. So AY, Cooper SB, Feldman BJ, Manuchehri M, Yamamoto KR. 2008. Conservation analysis predicts in vivo occupancy of glucocorticoid receptor-binding sequences at glucocorticoid-induced genes. Proc. Natl. Acad. Sci. U. S. A. 105:5745-5749. http://dx.doi.org/10.1073/pnas.0801551105.
29. Blind RD, Garabedian MJ. 2008. Differential recruitment of glucocorticoid receptor phospho-isoforms to glucocorticoid-induced genes. J. Steroid Biochem. Mol. Biol. 109:150-157. http://dx.doi.org/10.1016/j.jsbmb.2008.01.002.
30. Yu CY, Mayba O, Lee JV, Tran J, Harris C, Speed TP, Wang JC. 2010. Genome-wide analysis of glucocorticoid receptor binding regions in adipocytes reveal gene network involved in triglyceride homeostasis. PLoS One 5:e15188. http://dx.doi.org/10.1371/journal.pone.0015188.
31. Steger DJ, Grant GR, Schupp M, Tomaru T, Lefterova MI, Schug J, Manduchi E, Stoeckert CJ, Jr., Lazar MA. 2010. Propagation of adipogenic signals through an epigenomic transition state. Genes Dev. 24:1035-1044. http://dx.doi.org/10.1101/gad.1907110.
32. John S, Sabo PJ, Thurman RE, Sung MH, Biddie SC, Johnson TA, Hager GL, Stamatoyannopoulos JA. 2011. Chromatin accessibility predetermines glucocorticoid receptor binding patterns. Nat. Genet. 43:264-268. http://dx.doi.org/10.1038/ng.759.
33. Siersbaek R, Nielsen R, John S, Sung MH, Baek S, Loft A, Hager GL, Mandrup S. 2011. Extensive chromatin remodeling and establishment of transcription factor "hot spots" during early adipogenesis. EMBO J. 30:1459-1472. http://dx.doi.org/10.1038/emboj.2011.65.
34. Malmersjo S, Rebellato P, Smedler E, Planert H, Kanatani S, Liste I, Nanou E, Sunner H, Abdelhady S, Zhang S, Andang M, El Manira A, Silberberg G, Arenas E, Uhlen P. 2013. Neural progenitors organize in small-world networks to promote cell proliferation. Proc. Natl. Acad. Sci. U. S. A. 110:E1524-E1532. http://dx.doi.org/10.1073/pnas.1220179110.
35. Mercier I, Casimiro MC, Zhou J, Wang C, Plymire C, Bryant KG, Daumer KM, Sotgia F, Bonuccelli G, Witkiewicz AK, Lin J, Tran TH, Milliman J, Frank PG, Jasmin JF, Rui H, Pestell RG, Lisanti MP. 2009. Genetic ablation of caveolin-1 drives estrogen-hypersensitivity and the development of DCIS-like mammary lesions. Am. J. Pathol. 174:1172-1190. http://dx.doi.org/10.2353/ajpath.2009.080882.
36. Sippel M, Rajala R, Korhonen L, Bornhauser B, Sokka AL, Naito M, Lindholm D. 2009. Dexamethasone regulates expression of BRUCE/Apollon and the proliferation of neural progenitor cells. FEBS Lett. 583:2213-2217. http://dx.doi.org/10.1016/j.febslet.2009.06.018.
37. Sanna E, Miotti S, Mazzi M, De Santis G, Canevari S, Tomassetti A. 2007. Binding of nuclear caveolin-1 to promoter elements of growthassociated genes in ovarian carcinoma cells. Exp. Cell Res. 313:1307-1317. http://dx.doi.org/10.1016/j.yexcr.2007.02.005.
38. Li W, Liu H, Zhou JS, Cao JF, Zhou XB, Choi AM, Chen ZH, Shen HH. 2012. Caveolin-1 inhibits expression of antioxidant enzymes through direct interaction with nuclear erythroid 2 p45-related Factor-2 (Nrf2). J. Biol. Chem. 287:20922-20930. http://dx.doi.org/10.1074/jbc. M112.352336.
39. Galliher-Beckley AJ, Williams JG, Collins JB, Cidlowski JA. 2008. Glycogen synthase kinase 3ß-mediated serine phosphorylation of the human glucocorticoid receptor redirects gene expression profiles. Mol. Cell. Biol. 28:7309-7322. http://dx.doi.org/10.1128/MCB.00808-08.
40. Wong WP, Tiano JP, Liu S, Hewitt SC, Le May C, Dalle S, Katzenellenbogen JA, Katzenellenbogen BS, Korach KS, Mauvais-Jarvis F. 2010. Extranuclear estrogen receptor-alpha stimulates NeuroD1 binding to the insulin promoter and favors insulin synthesis. Proc. Natl. Acad. Sci. U. S. A. 107:13057-13062. http://dx.doi.org/10.1073/pnas.0914501107.
41. Hauger RL, Olivares-Reyes JA, Dautzenberg FM, Lohr JB, Braun S, Oakley RH. 2012. Molecular and cell signaling targets for PTSD pathophysiology and pharmacotherapy. Neuropharmacology 62:705-714. http://dx.doi.org/10.1016/j.neuropharm.2011.11.007.
42. Gioiosa L, Raggi C, Ricceri L, Jasmin JF, Frank PG, Capozza F, Lisanti MP, Alleva E, Sargiacomo M, Laviola G. 2008. Altered emotionality, spatial memory and cholinergic function in caveolin-1 knockout mice. Behav. Brain Res. 188:255-262.
43. Ezan P, Andre P, Cisternino S, Saubamea B, Boulay AC, Doutremer S, Thomas MA, Quenech'du N, Giaume C, Cohen-Salmon M. 2012. Deletion of astroglial connexins weakens the blood-brain barrier. J. Cereb. Blood Flow Metab. 32:1457-1467. http://dx.doi.org/10.1038/jcbfm.2012.45.
44. Chen L, Chatterjee M, Li JY. 2010. The mouse homeobox gene Gbx2 is required for the development of cholinergic interneurons in the striatum. J. Neurosci. 30:14824-14834. http://dx.doi.org/10.1523/JNEUROSCI.3742-10.2010.
45. Xu B, Roos JL, Dexheimer P, Boone B, Plummer B, Levy S, Gogos JA, Karayiorgou M. 2011. Exome sequencing supports a de novo mutational paradigm for schizophrenia. Nat. Genet. 43:864-868. http://dx.doi.org/10.1038/ng.902.
46. Nethe M, Anthony EC, Fernandez-Borja M, Dee R, Geerts D, Hensbergen PJ, Deelder AM, Schmidt G, Hordijk PL. 2010. Focal-adhesion targeting links caveolin-1 to a Rac1-degradation pathway. J. Cell Sci. 123:1948-1958. http://dx.doi.org/10.1242/jcs.062919.
47. Li CC, Chiang TC, Wu TS, Pacheco-Rodriguez G, Moss J, Lee FJ. 2007. ARL4D recruits cytohesin-2/ARNO to modulate actin remodeling. Mol. Biol. Cell 18:4420-4437. http://dx.doi.org/10.1091/mbc. E07-02-0149.
48. Ho H, Soto Hopkin A, Kapadia R, Vasudeva P, Schilling J, Ganesan AK. 2013. RhoJ modulates melanoma invasion by altering actin cytoskeletal dynamics. Pigment Cell Melanoma Res. 26:218-225. http://dx.doi.org/10.1111/pcmr.12058.
49. Bodea GO, Spille JH, Abe P, Andersson AS, Acker-Palmer A, Stumm R, Kubitscheck U, Blaess S. 2014. Reelin and CXCL12 regulate distinct migratory behaviors during the development of the dopaminergic system. Development 141:661-673. http://dx.doi.org/10.1242/dev.099937.
50. Adzic M, Djordjevic J, Djordjevic A, Niciforovic A, Demonacos C, Radojcic M, Krstic-Demonacos M. 2009. Acute or chronic stress induce cell compartment-specific phosphorylation of glucocorticoid receptor and alter its transcriptional activity in Wistar rat brain. J. Endocrinol. 202:87-97. http://dx.doi.org/10.1677/JOE-08-0509.
51. Pancotti F, Roncuzzi L, Maggiolini M, Gasperi-Campani A. 2012. Caveolin-1 silencing arrests the proliferation of metastatic lung cancer cells through the inhibition of STAT3 signaling. Cell Signal. 24:1390-1397. http://dx.doi.org/10.1016/j.cellsig.2012.02.015.
52. Itani OA, Liu KZ, Cornish KL, Campbell JR, Thomas CP. 2002. Glucocorticoids stimulate human sgk1 gene expression by activation of a GRE in its 5=-flanking region. Am. J. Physiol. Endocrinol. Metab. 283:E971-E979.